Cognitive Reserve, Brain Reserve, APOEɛ4, and Cognition in Individuals with Subjective Cognitive Decline in the SILCODE Study.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2020
Historique:
pubmed: 24 5 2020
medline: 8 5 2021
entrez: 24 5 2020
Statut: ppublish

Résumé

Cognitive reserve (CR) and brain reserve (BR) could offer protective effects on cognition in the early stage of Alzheimer's disease (AD). However, the effects of CR or BR on cognition in individuals with subjective cognitive decline (SCD) are not clear. To explore the effects of CR and BR on cognition in subjects with SCD. We included 149 subjects from the Sino Longitudinal Study on Cognitive Decline (SILCODE) study. Education was used as a proxy for CR, and head circumference was used as a proxy for BR. Multiple linear regression models were conducted to examine the effects of CR and BR on cognitive scores. Furthermore, we assessed differences in effects between APOEɛ4 carriers with SCD (n = 35) and APOEɛ4 non-carriers with SCD (n = 114) and linear trends among 4 reserve levels (low BR/CR, high BR/low CR, low BR/high CR, and high BR/high CR). Both CR and BR had independent positive effects on multiple cognitive measures in SCD participants, and the effects of CR were greater than those of BR. CR has positive effects on cognitive measures in both APOEɛ4 carriers and non-carriers with SCD. However, the positive effects of BR on cognitive measures were observed in APOEɛ4 non-carriers with SCD but not in APOEɛ4 carriers with SCD. Furthermore, there was a linear trend toward better cognitive performance on all cognitive measures in the BR+/CR+ group, followed by the BR-/CR+, BR+/CR-, and BR-/CR-groups. This study suggests that both CR and BR have the potential to delay or slow cognitive decline in individuals with SCD.

Sections du résumé

BACKGROUND
Cognitive reserve (CR) and brain reserve (BR) could offer protective effects on cognition in the early stage of Alzheimer's disease (AD). However, the effects of CR or BR on cognition in individuals with subjective cognitive decline (SCD) are not clear.
OBJECTIVE
To explore the effects of CR and BR on cognition in subjects with SCD.
METHODS
We included 149 subjects from the Sino Longitudinal Study on Cognitive Decline (SILCODE) study. Education was used as a proxy for CR, and head circumference was used as a proxy for BR. Multiple linear regression models were conducted to examine the effects of CR and BR on cognitive scores. Furthermore, we assessed differences in effects between APOEɛ4 carriers with SCD (n = 35) and APOEɛ4 non-carriers with SCD (n = 114) and linear trends among 4 reserve levels (low BR/CR, high BR/low CR, low BR/high CR, and high BR/high CR).
RESULTS
Both CR and BR had independent positive effects on multiple cognitive measures in SCD participants, and the effects of CR were greater than those of BR. CR has positive effects on cognitive measures in both APOEɛ4 carriers and non-carriers with SCD. However, the positive effects of BR on cognitive measures were observed in APOEɛ4 non-carriers with SCD but not in APOEɛ4 carriers with SCD. Furthermore, there was a linear trend toward better cognitive performance on all cognitive measures in the BR+/CR+ group, followed by the BR-/CR+, BR+/CR-, and BR-/CR-groups.
CONCLUSION
This study suggests that both CR and BR have the potential to delay or slow cognitive decline in individuals with SCD.

Identifiants

pubmed: 32444543
pii: JAD200082
doi: 10.3233/JAD-200082
doi:

Substances chimiques

Apolipoprotein E4 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

249-260

Auteurs

Kun Yang (K)

Department of Evidence-based Medicine, Xuanwu Hospital of Capital Medical University, Beijing, China.

Guanqun Chen (G)

Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.
National Clinical Research Center for Geriatric Disorders, Beijing, China.

Can Sheng (C)

Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.

Yunyan Xie (Y)

Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.

Yuxia Li (Y)

Central Laboratory, Xuanwu Hospital, Capital Medical University, Beijing, China.

Xiaochen Hu (X)

Department of Psychiatry and Psychotherapy, University of Cologne, Medical Faculty, Cologne, Germany.

Yu Sun (Y)

Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.

Ying Han (Y)

Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.
Center of Alzheimer's Disease, Beijing Institute for Brain Disorders, Beijing, China.
National Clinical Research Center for Geriatric Disorders, Beijing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH